517 related articles for article (PubMed ID: 30509990)
1. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
[TBL] [Abstract][Full Text] [Related]
2. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
[TBL] [Abstract][Full Text] [Related]
3. Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.
Lee KW; Chen W; Junn E; Im JY; Grosso H; Sonsalla PK; Feng X; Ray N; Fernandez JR; Chao Y; Masliah E; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
J Neurosci; 2011 May; 31(19):6963-71. PubMed ID: 21562258
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease.
Lee KW; Im JY; Woo JM; Grosso H; Kim YS; Cristovao AC; Sonsalla PK; Schuster DS; Jalbut MM; Fernandez JR; Voronkov M; Junn E; Braithwaite SP; Stock JB; Mouradian MM
Neurotherapeutics; 2013 Jan; 10(1):143-53. PubMed ID: 23296837
[TBL] [Abstract][Full Text] [Related]
5. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
8. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
[TBL] [Abstract][Full Text] [Related]
9. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.
Basurto-Islas G; Blanchard J; Tung YC; Fernandez JR; Voronkov M; Stock M; Zhang S; Stock JB; Iqbal K
Neurobiol Aging; 2014 Dec; 35(12):2701-2712. PubMed ID: 25034344
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.
Koob AO; Ubhi K; Paulsson JF; Kelly J; Rockenstein E; Mante M; Adame A; Masliah E
Exp Neurol; 2010 Feb; 221(2):267-74. PubMed ID: 19944097
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E
J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537
[TBL] [Abstract][Full Text] [Related]
13. The novel mechanism of rotenone-induced α-synuclein phosphorylation via reduced protein phosphatase 2A activity.
Wang Y; Liu J; Chen M; Du T; Duan C; Gao G; Yang H
Int J Biochem Cell Biol; 2016 Jun; 75():34-44. PubMed ID: 27012437
[TBL] [Abstract][Full Text] [Related]
14. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L; Spencer B; Desplats P; Patrick C; Paulino A; Rockenstein E; Hansen L; Adame A; Galasko D; Masliah E
PLoS One; 2010 Feb; 5(2):e9313. PubMed ID: 20174468
[TBL] [Abstract][Full Text] [Related]
15. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
16. Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains.
Liu G; Chen M; Mi N; Yang W; Li X; Wang P; Yin N; Li Y; Yue F; Chan P; Yu S
Neurobiol Aging; 2015 Sep; 36(9):2649-59. PubMed ID: 26149921
[TBL] [Abstract][Full Text] [Related]
17. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.
Kim C; Spencer B; Rockenstein E; Yamakado H; Mante M; Adame A; Fields JA; Masliah D; Iba M; Lee HJ; Rissman RA; Lee SJ; Masliah E
Mol Neurodegener; 2018 Aug; 13(1):43. PubMed ID: 30092810
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
Yang W; Wang X; Duan C; Lu L; Yang H
Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
